Stockreport

Longeveron® to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

Longeveron Inc. - common stock  (LGVN) 
PDF MIAMI, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rar [Read more]